News
-

KLOW Peptide Myths: 10 Claims Checked
KLOW’s four ingredients have not been tested together in people. Ten common claims, checked against ingredient studies, FDA records and sport rules.
-

Thymosin Alpha 1 Vaccine Study: What It Found
A 1989 flu-vaccine trial found higher antibody levels in older men. That finding does not establish fewer infections or a general boost to immunity.
-

Can You Donate Blood on Semaglutide? Usually, Yes
Semaglutide usually does not rule out blood donation. Feeling well, meeting donor screening rules, and reviewing other medicines still matter.
-

Tesamorelin Cognitive Study: What SMART Found
SMART found a modest advantage on tests of attention, task switching and working memory. Its results do not establish dementia prevention or everyday memory gains.
-

Who Discovered Selank? The Russian Team Behind It
Russian teams built Selank from an older immune-system molecule called tuftsin. The record runs from a 1970 discovery to early rat experiments and Russian registration.
-

Flying With Tirzepatide: TSA and Storage Rules
Tirzepatide can travel in a carry-on. The details depend on TSA screening, the actual medication label, elapsed hours between doses, and destination rules.
-

Glow Peptide Side Effects: What We Know
Glow has no blend-specific safety study. The useful answer separates each ingredient’s evidence, the unknowns of combining them, and preparation quality.
-

Ipamorelin Clinical Trial: Main Goal Not Met
The published bowel-surgery trial found no significant benefit over placebo. Its short hospital course cannot establish muscle, sleep, or long-term results.
-

Selank Side Effects: What the Small Studies Show
Small Russian studies report some unwanted effects, but they leave long-term safety and many interaction questions open. Here is what each source actually measured.
-

Sugar Cravings on Semaglutide: Halloween Candy?
The labels don't forbid sweets, and a sweet tooth isn't a treatment score. Halloween planning is about comfort, blood sugar and medicines around children.
-

DEXA Scan Results Explained: What the Numbers Mean
A DEXA report separates fat, lean tissue and bone. Here’s what the numbers mean, how they changed in trials and why lean mass isn’t muscle alone.
-

Epitalon Myths: 10 Claims Checked Against Research
Epitalon's cell findings are real. They don't establish longer human life, better sleep, a yearly treatment schedule or freedom from side effects.
-

PT-141 Blood Pressure: What Changes After a Dose
PT-141 can briefly raise blood pressure and slow heart rate. The Vyleesi label explains why recent readings and heart history matter before prescribing.
-

Thymosin Alpha 1 vs Beta 4: What’s Different?
Alpha-1 and beta-4 share a discovery story, but their molecules, main jobs and human trials differ. TB-500 adds a separate fragment question.
-

KLOW vs Wolverine: How a Provider Chooses
Wolverine has two peptides; KLOW adds two more. For a sore elbow, the useful question is what the evidence covers and how a provider weighs the unknowns.
-

NAD IV Infusion Study: What the 2019 Pilot Found
The 2019 pilot tracked NAD+ in blood and urine. It helps explain how an infusion is processed, without establishing better energy or slower aging.
-

Semax for Stroke: What the Studies Actually Show
Semax has been studied alongside stroke care in Russia. Small human studies and rat experiments leave important questions about recovery unanswered.
-

Tirzepatide and Periods: Why Your Cycle Can Change
Period changes have been reported with tirzepatide, though they are not listed as human side effects in its labels. Weight changes, contraception and pregnancy also matter.
-

Who Discovered SS-31? Szeto and Schiller
Hazel Szeto and Peter Schiller developed SS-31 through work that began with pain-related peptides. Its history runs from an unexpected finding inside cells to elamipretide and Forzinity.
-

CJC-1295 Clinical Trial: What the 2006 Study Found
The 2006 study found lasting hormone changes in 66 healthy adults. Here’s what it measured, the side effects it recorded, and why the DAC distinction matters.
Page 5 of 27 · 528 articles